Post job

Akonni Biosystems executives

Work at Akonni Biosystems?
Share your experience

Rate Akonni Biosystems' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Charles Daitch

Board Member

Charles Daitch's LinkedIn

Dr. Daitch is the Founder of Akonni and has served as the CEO and Board member since its inception in 2003. He has 26 years of product development experience in integrated biosensors encompassing a broad range of disciplines including chemistry, biology, biomaterials, engineering, and chemical/biological defense. He manages and leads multidisciplinary teams of scientists and engineers focused on the development of next-generation in-vitro diagnostic devices. Dr. Daitch has experience in developing a wide variety of sensor system products for remote autonomous or point-of-use detection of complex samples employing miniaturized analyte purification, and specialty biomaterials interfaced with microfabricated detection components coupled to a variety signal transduction modalities. He brings strong product development and R&D experience from the NIH/FDA, USDA, Sandia National Labs and the Intelligence Community. In addition, he has commercial senior management experience (P&L responsibility) from PSR/Veridian, CUBRC, HandyLab, and Akonni. Dr. Daitch was recruited by HandyLab Inc., a microfluidics diagnostic company, to serve on the executive management team as Vice President of R&D. Prior, Dr. Daitch launched a biodefense product development facility and business unit for PSR/Veridian Corp., a premier DOD/IC contractor, and led the growth of the operation to 24 employees and >$5M in annual revenue. As the CEO of Akonni he is responsible for 1) setting and executing strategic direction, 2) product management, 3) leading equity financing rounds (>$30M to date), managing capital, financial audits, 4) corporate governance, shareholder relations, 5) leading business development, strategic partnerships, 6) recruiting, mentoring, listening and learning from our exceptional staff, and 7) setting the company’s culture. He has 5 U.S. patents, 24 publications and served as principle investigator on over $20 million in government grants and contracts.

Christopher Cooney

Board Member

Jon Davis

President

Rebecca Holmberg

Board Member

Brian Morra

Board Member

Chuck Parrish

Board Member

Lawrence Firestone

Exec VP/CFO

Lawrence Firestone joined Akonni as the Executive Vice President and Chief Financial Officer in April of 2018. Mr. Firestone draws on over 35 years of executive management experience in both public and private technology companies as a C-level executive. Most recently, since February 2014, Mr. Firestone was the Chief Executive Officer and President, and is now the Chairman of FirePower Technology, Inc. a provider of power supplies to the high-performance computing market. Prior to FirePower Technology, from June 2012 to July 2013, Mr. Firestone was Chief Executive Officer and President of Qualstar Corporation, a provider of power supplies for high performance computing, instrumentation and tape libraries – markets where large amounts of electronic data are stored and maintained. From February 2011 to May 2012, Mr. Firestone served as Chief Financial Officer of X-IO Technology Corporation, a supplier of enterprise storage systems. From 2006 to 2010, Mr. Firestone was Executive Vice President and Chief Financial Officer of Advanced Energy Industries, Inc., a provider of power conversion devices for the semi-conductor and solar inverter markets. From 1999 until 2006, Mr. Firestone served as the Senior Vice President and Chief Financial Officer at Applied Films Corporation, a supplier of thin film deposition equipment. Prior to joining Applied Films, from 1996 to 1999, Mr. Firestone served as Vice President and Chief Operating Officer of Avalanche Industries, a contract manufacturer of custom cables and harnesses. Prior to joining Avalanche Industries, Mr. Firestone held executive management positions at Woolson Spice and Coffee Company, Honolulu, HI, TechniStar Corporation, Longmont, CO and Colorado Manufacturing Technology, Inc., Colorado Springs, CO. Mr. Firestone’s public company board experience includes CVD Equipment (Symbol: CVV), Qualstar Corporation (Symbol: QBAK), Amtech Systems, Inc. (Symbol: ASYS) and Hyperspace Communications, Inc. (Symbol: HCO). Mr. Firestone received a B.S. in Business Administration with a concentration in Accounting from Slippery Rock University.

Thomas Higgins

Chairman

Tom McMahon

Board Member

Do you work at Akonni Biosystems?

Does the leadership team provide a clear direction for Akonni Biosystems?

Akonni Biosystems jobs

Akonni Biosystems founders

Name & TitleBio
Charles Daitch

Board Member

Charles Daitch's LinkedIn

Dr. Daitch is the Founder of Akonni and has served as the CEO and Board member since its inception in 2003. He has 26 years of product development experience in integrated biosensors encompassing a broad range of disciplines including chemistry, biology, biomaterials, engineering, and chemical/biological defense. He manages and leads multidisciplinary teams of scientists and engineers focused on the development of next-generation in-vitro diagnostic devices. Dr. Daitch has experience in developing a wide variety of sensor system products for remote autonomous or point-of-use detection of complex samples employing miniaturized analyte purification, and specialty biomaterials interfaced with microfabricated detection components coupled to a variety signal transduction modalities. He brings strong product development and R&D experience from the NIH/FDA, USDA, Sandia National Labs and the Intelligence Community. In addition, he has commercial senior management experience (P&L responsibility) from PSR/Veridian, CUBRC, HandyLab, and Akonni. Dr. Daitch was recruited by HandyLab Inc., a microfluidics diagnostic company, to serve on the executive management team as Vice President of R&D. Prior, Dr. Daitch launched a biodefense product development facility and business unit for PSR/Veridian Corp., a premier DOD/IC contractor, and led the growth of the operation to 24 employees and >$5M in annual revenue. As the CEO of Akonni he is responsible for 1) setting and executing strategic direction, 2) product management, 3) leading equity financing rounds (>$30M to date), managing capital, financial audits, 4) corporate governance, shareholder relations, 5) leading business development, strategic partnerships, 6) recruiting, mentoring, listening and learning from our exceptional staff, and 7) setting the company’s culture. He has 5 U.S. patents, 24 publications and served as principle investigator on over $20 million in government grants and contracts.

Akonni Biosystems board members

Name & TitleBio
Charles Daitch

Board Member

Charles Daitch's LinkedIn

Dr. Daitch is the Founder of Akonni and has served as the CEO and Board member since its inception in 2003. He has 26 years of product development experience in integrated biosensors encompassing a broad range of disciplines including chemistry, biology, biomaterials, engineering, and chemical/biological defense. He manages and leads multidisciplinary teams of scientists and engineers focused on the development of next-generation in-vitro diagnostic devices. Dr. Daitch has experience in developing a wide variety of sensor system products for remote autonomous or point-of-use detection of complex samples employing miniaturized analyte purification, and specialty biomaterials interfaced with microfabricated detection components coupled to a variety signal transduction modalities. He brings strong product development and R&D experience from the NIH/FDA, USDA, Sandia National Labs and the Intelligence Community. In addition, he has commercial senior management experience (P&L responsibility) from PSR/Veridian, CUBRC, HandyLab, and Akonni. Dr. Daitch was recruited by HandyLab Inc., a microfluidics diagnostic company, to serve on the executive management team as Vice President of R&D. Prior, Dr. Daitch launched a biodefense product development facility and business unit for PSR/Veridian Corp., a premier DOD/IC contractor, and led the growth of the operation to 24 employees and >$5M in annual revenue. As the CEO of Akonni he is responsible for 1) setting and executing strategic direction, 2) product management, 3) leading equity financing rounds (>$30M to date), managing capital, financial audits, 4) corporate governance, shareholder relations, 5) leading business development, strategic partnerships, 6) recruiting, mentoring, listening and learning from our exceptional staff, and 7) setting the company’s culture. He has 5 U.S. patents, 24 publications and served as principle investigator on over $20 million in government grants and contracts.

Christopher Cooney

Board Member

Rebecca Holmberg

Board Member

Brian Morra

Board Member

Chuck Parrish

Board Member

Tom McMahon

Board Member

Akonni Biosystems executives FAQs

Zippia gives an in-depth look into the details of Akonni Biosystems, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Akonni Biosystems. The employee data is based on information from people who have self-reported their past or current employments at Akonni Biosystems. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Akonni Biosystems. The data presented on this page does not represent the view of Akonni Biosystems and its employees or that of Zippia.

Akonni Biosystems may also be known as or be related to AKONNI BIOSYSTEMS INC, Akonni Biosystems, Akonni Biosystems Inc and Akonni Biosystems, Inc.